Promising Strategies to Reduce Risk of Alzheimer’s Disease

Written by Dr Peter McCullough MD, MPH on July 2, 2024. Posted in Current News

I have recently posted a Substack about the bona fide risk of progressive cognitive decline and Alzheimer’s disease after COVID-19 vaccination

In a fascinating new book; The Indoctrinated Brain: How to Successfully Fend Off the Global Attack on Your Mental Freedom, Dr. Michael Nehls suggests that both COVID-19 infection and the vaccines can promote dementia due to amyloid formation or folding of the SARS-CoV-2 Spike protein within the brain.

Navolokin et al, have published a review focusing on SARS-CoV-2 infection and the mechanisms by which dementia could be worsened.

All of the processes mentioned by the authors could apply to COVID-19 vaccines which expose the body to far more Spike protein than SARS-CoV-2 infection, particularly if it has been treated early with the McCullough Protocol.

“This review highlights new discoveries in the field of COVID-19-mediated amyloid accumulation in the brain associated with the neurological symptoms and the development of promising strategies to stimulate clearance of amyloids from the brain through lymphatic and other pathways.

These strategies are based on innovative methods of treating brain dysfunction induced by COVID-19 infection, including the use of photobiomodulation, plasmalogens, and medicinal herbs, which offer hope for addressing the challenges posed by the SARS-CoV-2 virus.”

This review highlights the need for high quality epidemiological studies to evaluate the risks of dementia after infection and vaccination with the numbers of Spike protein exposures as the independent variable.

Since vaccine failure, most vaccinated individuals have suffered SARS-CoV-2 infection as a second, third, etc exposure.

Furthermore, large randomized placebo controlled trials are needed for the most biologically active and promising among the compounds discussed.

Like current prescription Alzheimer’s treatments, the most effective strategy will be to start early before there is any significant cognitive decline.

See more here substack.com

Header image: National Institute on Aging

Please Donate Below To Support Our Ongoing Work To Defend The Scientific Method

PRINCIPIA SCIENTIFIC INTERNATIONAL, legally registered in the UK as a company incorporated for charitable purposes. Head Office: 27 Old Gloucester Street, London WC1N 3AX. 

Trackback from your site.